AG-NOR was determined in the nuclei of thirty-five urinary bladder lesions, varying between benign and malignant schistosomal lesions and non schistosomal ones. The results showed that the assessment of AG-NOR in urinary bladder lesions can be valuable in distinguishing benign from malignant lesions of the urinary bladder and can be used as a prognostic parameter.